Chrysemys picta bellii isolate RCT428 chromosome 6, Chrysemys_picta_BioNano-3.0.4, whole genome shotgun sequence.
Chrysemys picta bellii (western painted turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Chrysemys.
Physical Mapping and Refinement of the Painted Turtle Genome (Chrysemys picta) Inform Amniote Genome Evolution and Challenge Turtle-Bird Chromosomal Conservation
REFSEQ INFORMATION: The reference sequence is identical to\nCM002660.2.\nOn Aug 10, 2021 this sequence version replaced NC_024223.1.\nAssembly name: Chrysemys_picta_BioNano-3.0.4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Painted turtle genome\nsequencing consortium on 2020/08/21. The original whole-genome\nshotgun project has the accession AHGY00000000.3.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Painted turtle genome sequencing\n consortium\nAssembly Method :: Newbler v. 2.6\nAssembly Name :: Chrysemys_picta_BioNano-3.0.4\nGenome Coverage :: 19.2x\nSequencing Technology :: 454 Life Sciences\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chrysemys picta Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
small lake 1.3 miles south of Potholes Reservoir
Derived by automated computational analysis using gene prediction method: Gnomon.
transmembrane 131 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
transmembrane 131 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
transmembrane 131 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
transmembrane protein 131-like isoform X3
transmembrane protein 131-like isoform X2
transmembrane protein 131-like isoform X1
meiotic nuclear divisions 1, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
meiotic nuclear divisions 1, transcript variant X2
meiotic nuclear division protein 1 homolog isoform X1
meiotic nuclear division protein 1 homolog isoform X2
meiotic nuclear divisions 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tripartite motif containing 2, transcript variant X13
tripartite motif containing 2, transcript variant X3
tripartite motif containing 2, transcript variant X14
tripartite motif containing 2, transcript variant X4
tripartite motif containing 2, transcript variant X6
tripartite motif containing 2, transcript variant X7
tripartite motif containing 2, transcript variant X1
tripartite motif containing 2, transcript variant X15
tripartite motif containing 2, transcript variant X10
tripartite motif containing 2, transcript variant X11
tripartite motif containing 2, transcript variant X8
tripartite motif containing 2, transcript variant X9
tripartite motif containing 2, transcript variant X12
tripartite motif containing 2, transcript variant X2
tripartite motif containing 2, transcript variant X5
tripartite motif containing 2, transcript variant X16
tripartite motif-containing protein 2 isoform X2
tripartite motif-containing protein 2 isoform X1
tripartite motif-containing protein 2 isoform X3
FH2 domain containing 1, transcript variant X1
FH2 domain containing 1, transcript variant X4
FH2 domain containing 1, transcript variant X3
FH2 domain containing 1, transcript variant X2
ADP ribosylation factor interacting protein 1, transcript variant X5
ADP ribosylation factor interacting protein 1, transcript variant X3
ADP ribosylation factor interacting protein 1, transcript variant X1
ADP ribosylation factor interacting protein 1, transcript variant X2
ADP ribosylation factor interacting protein 1, transcript variant X4
tigger transposable element derived 4, transcript variant X2
tigger transposable element derived 4, transcript variant X1
tigger transposable element derived 4, transcript variant X3
tigger transposable element-derived protein 4
transmembrane protein 154, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
transmembrane protein 154, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 154, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
F-box and WD repeat domain containing 7, transcript variant X4
F-box and WD repeat domain containing 7, transcript variant X3
F-box and WD repeat domain containing 7, transcript variant X5
F-box and WD repeat domain containing 7, transcript variant X2
F-box and WD repeat domain containing 7, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
F-box and WD repeat domain containing 7, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
F-box and WD repeat domain containing 7, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
F-box and WD repeat domain containing 7, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
F-box and WD repeat domain containing 7, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
F-box and WD repeat domain containing 7, transcript variant X1
F-box/WD repeat-containing protein 7 isoform X1
F-box/WD repeat-containing protein 7 isoform X5
F-box/WD repeat-containing protein 7 isoform X6
F-box/WD repeat-containing protein 7 isoform X7
uncharacterized LOC101946971, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC101946971, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
F-box/WD repeat-containing protein 7 isoform X2
F-box and WD repeat domain containing 7, transcript variant X7
F-box/WD repeat-containing protein 7 isoform X4
F-box and WD repeat domain containing 7, transcript variant X6
F-box/WD repeat-containing protein 7 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glutamyl-tRNA amidotransferase subunit B, transcript variant X2
glutamyl-tRNA amidotransferase subunit B, transcript variant X1
glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial
FHF complex subunit HOOK interacting protein 1A
SH3 domain containing 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SH3 domain containing 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00071
lipopolysaccharide-responsive and beige-like anchor protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
lipopolysaccharide-responsive and beige-like anchor protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
lipopolysaccharide-responsive and beige-like anchor protein, transcript variant X1
lipopolysaccharide-responsive and beige-like anchor protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
lipopolysaccharide-responsive and beige-like anchor protein isoform X1
lipopolysaccharide-responsive and beige-like anchor protein isoform X3
lipopolysaccharide-responsive and beige-like anchor protein isoform X2
lipopolysaccharide-responsive and beige-like anchor protein
doublecortin like kinase 2, transcript variant X2
doublecortin like kinase 2, transcript variant X1
doublecortin like kinase 2, transcript variant X6
serine/threonine-protein kinase DCLK2 isoform X2
serine/threonine-protein kinase DCLK2 isoform X1
serine/threonine-protein kinase DCLK2 isoform X4
doublecortin like kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
doublecortin like kinase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
doublecortin like kinase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
serine/threonine-protein kinase DCLK2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Rho GTPase activating protein 10, transcript variant X2
Rho GTPase activating protein 10, transcript variant X1
rho GTPase-activating protein 10 isoform X1
Rho GTPase activating protein 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Rho GTPase activating protein 10, transcript variant X5
Rho GTPase activating protein 10, transcript variant X4
rho GTPase-activating protein 10 isoform X2
protein arginine methyltransferase 9, transcript variant X8
protein arginine methyltransferase 9, transcript variant X4
protein arginine methyltransferase 9, transcript variant X6
protein arginine methyltransferase 9, transcript variant X1
protein arginine methyltransferase 9, transcript variant X3
protein arginine methyltransferase 9, transcript variant X7
protein arginine methyltransferase 9, transcript variant X2
protein arginine methyltransferase 9, transcript variant X5
protein arginine N-methyltransferase 9 isoform X1
protein arginine N-methyltransferase 9 isoform X2
transmembrane protein 184C, transcript variant X2
transmembrane protein 184C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
tetratricopeptide repeat domain 29, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tetratricopeptide repeat domain 29, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tetratricopeptide repeat domain 29, transcript variant X3
tetratricopeptide repeat domain 29, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 4, transcription factor 2
solute carrier family 10 member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 10 member 7, transcript variant X1
sodium/bile acid cotransporter 7 isoform X1
sodium/bile acid cotransporter 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X2
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X1
U6 snRNA-associated Sm-like protein LSm6
zinc finger protein 827, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
zinc finger protein 827, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
zinc finger protein 827, transcript variant X2
zinc finger protein 827, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
metabolism of cobalamin associated A, transcript variant X1
metabolism of cobalamin associated A, transcript variant X2
metabolism of cobalamin associated A, transcript variant X4
metabolism of cobalamin associated A, transcript variant X3
methylmalonic aciduria type A protein, mitochondrial isoform X2
methylmalonic aciduria type A protein, mitochondrial isoform X1
methylmalonic aciduria type A protein, mitochondrial isoform X3
SMAD family member 1, transcript variant X1
SMAD family member 1, transcript variant X2
mothers against decapentaplegic homolog 1
OTU deubiquitinase 4, transcript variant X1
OTU deubiquitinase 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
OTU deubiquitinase 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
OTU deubiquitinase 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
OTU deubiquitinase 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
OTU deubiquitinase 4, transcript variant X2
OTU deubiquitinase 4, transcript variant X3
OTU domain-containing protein 4 isoform X1
OTU domain-containing protein 4 isoform X3
OTU domain-containing protein 4 isoform X4
OTU domain-containing protein 4 isoform X5
OTU deubiquitinase 4, transcript variant X4
OTU domain-containing protein 4 isoform X2
ATP binding cassette subfamily E member 1
ATP-binding cassette sub-family E member 1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
anaphase promoting complex subunit 10, transcript variant X4
anaphase promoting complex subunit 10, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
anaphase promoting complex subunit 10, transcript variant X8
anaphase promoting complex subunit 10, transcript variant X3
anaphase promoting complex subunit 10, transcript variant X5
anaphase promoting complex subunit 10, transcript variant X6
anaphase promoting complex subunit 10, transcript variant X1
anaphase promoting complex subunit 10, transcript variant X2
anaphase promoting complex subunit 10, transcript variant X9
anaphase-promoting complex subunit 10 isoform X1
anaphase-promoting complex subunit 10 isoform X3
anaphase-promoting complex subunit 10 isoform X2
hedgehog interacting protein, transcript variant X2
hedgehog interacting protein, transcript variant X1
uncharacterized LOC101946261, transcript variant X3
uncharacterized LOC101946261, transcript variant X4
uncharacterized LOC101946261, transcript variant X1
uncharacterized LOC101946261, transcript variant X2
uncharacterized protein LOC101946261 isoform X1
uncharacterized protein LOC101946261 isoform X4
uncharacterized protein LOC101946261 isoform X2
uncharacterized protein LOC101946261 isoform X3
FRAS1 related extracellular matrix 3, transcript variant X2
FRAS1 related extracellular matrix 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
FRAS1 related extracellular matrix 3, transcript variant X1
FRAS1-related extracellular matrix protein 3 isoform X2
FRAS1-related extracellular matrix protein 3 isoform X1
FRAS1-related extracellular matrix protein 3 isoform X3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5
GRB2 associated binding protein 1, transcript variant X2
GRB2 associated binding protein 1, transcript variant X5
GRB2 associated binding protein 1, transcript variant X1
GRB2 associated binding protein 1, transcript variant X4
GRB2 associated binding protein 1, transcript variant X3
GRB2 associated binding protein 1, transcript variant X6
GRB2 associated binding protein 1, transcript variant X9
GRB2 associated binding protein 1, transcript variant X8
GRB2 associated binding protein 1, transcript variant X12
GRB2 associated binding protein 1, transcript variant X7
GRB2-associated-binding protein 1 isoform X6
GRB2-associated-binding protein 1 isoform X3
GRB2-associated-binding protein 1 isoform X5
GRB2-associated-binding protein 1 isoform X4
GRB2-associated-binding protein 1 isoform X2
GRB2-associated-binding protein 1 isoform X1
GRB2-associated-binding protein 1 isoform X7
GRB2-associated-binding protein 1 isoform X10
GRB2 associated binding protein 1, transcript variant X10
GRB2 associated binding protein 1, transcript variant X11
GRB2-associated-binding protein 1 isoform X9
GRB2-associated-binding protein 1 isoform X8
uncharacterized LOC112059235, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC112059235, transcript variant X1
ubiquitin specific peptidase 38, transcript variant X3
ubiquitin specific peptidase 38, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 38 isoform X3
ubiquitin carboxyl-terminal hydrolase 38 isoform X1
ubiquitin specific peptidase 38, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 38 isoform X2
inositol polyphosphate-4-phosphatase type II B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
inositol polyphosphate-4-phosphatase type II B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
inositol polyphosphate-4-phosphatase type II B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inositol polyphosphate-4-phosphatase type II B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
inositol polyphosphate-4-phosphatase type II B, transcript variant X3
inositol polyphosphate-4-phosphatase type II B, transcript variant X2
inositol polyphosphate 4-phosphatase type II isoform X2
inositol polyphosphate 4-phosphatase type II isoform X4
inositol polyphosphate 4-phosphatase type II isoform X1
inositol polyphosphate 4-phosphatase type II isoform X3
uncharacterized LOC112059236, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC112059236, transcript variant X4
uncharacterized LOC112059236, transcript variant X3
uncharacterized LOC112059236, transcript variant X5
uncharacterized LOC112059236, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC112059236, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC101949174, transcript variant X2
uncharacterized LOC101949174, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
TBC1 domain family member 9, transcript variant X1
TBC1 domain family member 9, transcript variant X3
TBC1 domain family member 9, transcript variant X5
TBC1 domain family member 9, transcript variant X2
TBC1 domain family member 9, transcript variant X4
ELMO domain containing 2, transcript variant X9
ELMO domain containing 2, transcript variant X5
ELMO domain containing 2, transcript variant X3
ELMO domain containing 2, transcript variant X6
ELMO domain containing 2, transcript variant X1
ELMO domain containing 2, transcript variant X7
ELMO domain containing 2, transcript variant X8
ELMO domain containing 2, transcript variant X2
ELMO domain containing 2, transcript variant X4
MGAT4 family member D, transcript variant X2
MGAT4 family member D, transcript variant X5
MGAT4 family member D, transcript variant X3
MGAT4 family member D, transcript variant X6
MGAT4 family member D, transcript variant X1
MGAT4 family member D, transcript variant X4
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D isoform X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D isoform X4
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
short coiled-coil protein, transcript variant X1
short coiled-coil protein, transcript variant X2
short coiled-coil protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mastermind like transcriptional coactivator 3, transcript variant X2
mastermind like transcriptional coactivator 3, transcript variant X1
mastermind like transcriptional coactivator 3, transcript variant X3
mastermind like transcriptional coactivator 3, transcript variant X4
microsomal glutathione S-transferase 2, transcript variant X9
microsomal glutathione S-transferase 2, transcript variant X5
microsomal glutathione S-transferase 2, transcript variant X2
microsomal glutathione S-transferase 2, transcript variant X3
microsomal glutathione S-transferase 2, transcript variant X7
microsomal glutathione S-transferase 2, transcript variant X8
microsomal glutathione S-transferase 2, transcript variant X1
microsomal glutathione S-transferase 2, transcript variant X6
microsomal glutathione S-transferase 2 isoform X2
microsomal glutathione S-transferase 2 isoform X8
microsomal glutathione S-transferase 2 isoform X5
microsomal glutathione S-transferase 2 isoform X7
microsomal glutathione S-transferase 2 isoform X6
microsomal glutathione S-transferase 2 isoform X3
microsomal glutathione S-transferase 2 isoform X1
microsomal glutathione S-transferase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
microsomal glutathione S-transferase 2 isoform X4
SET domain containing 7, histone lysine methyltransferase, transcript variant X1
SET domain containing 7, histone lysine methyltransferase, transcript variant X3
SET domain containing 7, histone lysine methyltransferase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
SET domain containing 7, histone lysine methyltransferase, transcript variant X2
SET domain containing 7, histone lysine methyltransferase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
SET domain containing 7, histone lysine methyltransferase, transcript variant X5
histone-lysine N-methyltransferase SETD7 isoform X1
histone-lysine N-methyltransferase SETD7 isoform X3
histone-lysine N-methyltransferase SETD7 isoform X2
uncharacterized LOC101932292, transcript variant X6
uncharacterized LOC101932292, transcript variant X2
uncharacterized LOC101932292, transcript variant X1
uncharacterized LOC101932292, transcript variant X3
uncharacterized LOC101932292, transcript variant X5
uncharacterized LOC101932292, transcript variant X7
uncharacterized LOC101932292, transcript variant X4
uncharacterized protein LOC101932292 isoform X1
uncharacterized protein LOC101932292 isoform X2
N-alpha-acetyltransferase 15, NatA auxiliary subunit, transcript variant X2
N-alpha-acetyltransferase 15, NatA auxiliary subunit, transcript variant X1
N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform X2
N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform X1
N-alpha-acetyltransferase 15, NatA auxiliary subunit, transcript variant X3
N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform X3
NADH:ubiquinone oxidoreductase subunit C1, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial isoform X1
NADH:ubiquinone oxidoreductase subunit C1, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial isoform X2
mitochondria localized glutamic acid rich protein
E74 like ETS transcription factor 2, transcript variant X3
E74 like ETS transcription factor 2, transcript variant X2
E74 like ETS transcription factor 2, transcript variant X1
E74 like ETS transcription factor 2, transcript variant X4
ETS-related transcription factor Elf-2 isoform X1
E74 like ETS transcription factor 2, transcript variant X5
ETS-related transcription factor Elf-2 isoform X2
uncharacterized LOC122173717, transcript variant X1
uncharacterized LOC122173717, transcript variant X2
solute carrier family 7 member 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 7 member 11, transcript variant X5
solute carrier family 7 member 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 7 member 11, transcript variant X2
solute carrier family 7 member 11, transcript variant X1
cystine/glutamate transporter isoform X2
cystine/glutamate transporter isoform X1
cystine/glutamate transporter isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
schlafen family member 13, transcript variant X2
schlafen family member 13, transcript variant X1
atrial natriuretic peptide-converting enzyme, transcript variant X3
atrial natriuretic peptide-converting enzyme isoform X3
atrial natriuretic peptide-converting enzyme, transcript variant X4
atrial natriuretic peptide-converting enzyme isoform X4
atrial natriuretic peptide-converting enzyme, transcript variant X7
atrial natriuretic peptide-converting enzyme, transcript variant X9
atrial natriuretic peptide-converting enzyme, transcript variant X1
atrial natriuretic peptide-converting enzyme, transcript variant X8
atrial natriuretic peptide-converting enzyme, transcript variant X2
atrial natriuretic peptide-converting enzyme, transcript variant X11
atrial natriuretic peptide-converting enzyme, transcript variant X5
atrial natriuretic peptide-converting enzyme, transcript variant X12
atrial natriuretic peptide-converting enzyme, transcript variant X6
atrial natriuretic peptide-converting enzyme, transcript variant X13
atrial natriuretic peptide-converting enzyme isoform X1
atrial natriuretic peptide-converting enzyme isoform X2
atrial natriuretic peptide-converting enzyme isoform X5
atrial natriuretic peptide-converting enzyme isoform X6
atrial natriuretic peptide-converting enzyme isoform X11
atrial natriuretic peptide-converting enzyme isoform X8
atrial natriuretic peptide-converting enzyme isoform X12
atrial natriuretic peptide-converting enzyme isoform X13
atrial natriuretic peptide-converting enzyme isoform X7
atrial natriuretic peptide-converting enzyme isoform X9
atrial natriuretic peptide-converting enzyme, transcript variant X10
atrial natriuretic peptide-converting enzyme isoform X10
ATPase phospholipid transporting 10D (putative), transcript variant X4
ATPase phospholipid transporting 10D (putative), transcript variant X9
ATPase phospholipid transporting 10D (putative), transcript variant X7
ATPase phospholipid transporting 10D (putative), transcript variant X6
ATPase phospholipid transporting 10D (putative), transcript variant X5
ATPase phospholipid transporting 10D (putative), transcript variant X1
ATPase phospholipid transporting 10D (putative), transcript variant X2
ATPase phospholipid transporting 10D (putative), transcript variant X3
ATPase phospholipid transporting 10D (putative), transcript variant X8
ATPase phospholipid transporting 10D (putative), transcript variant X10
phospholipid-transporting ATPase VD isoform X4
phospholipid-transporting ATPase VD isoform X6
phospholipid-transporting ATPase VD isoform X3
phospholipid-transporting ATPase VD isoform X2
phospholipid-transporting ATPase VD isoform X1
phospholipid-transporting ATPase VD isoform X5
phospholipid-transporting ATPase VD isoform X7
gamma-aminobutyric acid type A receptor subunit beta1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit beta-1
gamma-aminobutyric acid type A receptor subunit alpha4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit alpha4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit alpha4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit alpha4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-4 isoform X1
gamma-aminobutyric acid receptor subunit alpha-4 isoform X2
gamma-aminobutyric acid receptor subunit alpha-4 isoform X4
gamma-aminobutyric acid receptor subunit alpha-4 isoform X3
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X4
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X5
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X1
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-2 isoform X1
gamma-aminobutyric acid receptor subunit alpha-2 isoform X4
gamma-aminobutyric acid receptor subunit alpha-2 isoform X2
gamma-aminobutyric acid receptor subunit alpha-2 isoform X5
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X3
gamma-aminobutyric acid receptor subunit alpha-2 isoform X3
gamma-aminobutyric acid type A receptor subunit gamma1, transcript variant X5
gamma-aminobutyric acid type A receptor subunit gamma1, transcript variant X2
gamma-aminobutyric acid type A receptor subunit gamma1, transcript variant X3
gamma-aminobutyric acid type A receptor subunit gamma1, transcript variant X1
gamma-aminobutyric acid receptor subunit gamma-1 isoform X1
gamma-aminobutyric acid receptor subunit gamma-1 isoform X2
gamma-aminobutyric acid receptor subunit gamma-1 isoform X3
gamma-aminobutyric acid receptor subunit gamma-1 isoform X5
gamma-aminobutyric acid type A receptor subunit gamma1, transcript variant X4
gamma-aminobutyric acid receptor subunit gamma-1 isoform X4